Literature DB >> 8911945

Indocyanine-green angiography in patients with occult choroidal neovascularization.

S Wolf1, H Knabben, G Krombach, A Schaaf, U Solbach, M Reim.   

Abstract

Several studies have stressed the role of indocyanine-green (ICG) angiography in patients with occult choroidal neovascularization (O-CNV) secondary to age-related maculopathy (ARM). The present study was undertaken to evaluate the percentage of eyes that could be converted from O-CNV without suffering pigment epithelial detachment (PED) in well-defined CNV using ICG angiography with a scanning laser system. A total of 112 patients with ARM and O-CNV without PED were included in this prospective study. All patients underwent ICG angiography with a scanning laser system. The early phase (first 3 min) of the ICG angiogram was analyzed for the presence of a neovascular network, whereas focal or irregular hyperfluorescence was noted in the late phase. The early phase of the ICG angiograms revealed in 62 (55%) eyes a well-defined CNV. In 55 of these eyes, late irregular hyperfluorescent and hypofluorescent zones were observed. Another 27 eyes presented with focal hyperfluorescent areas in the latephase studies without having shown a well-demarcated area of neovascularization in the early phase of the ICG angiogram. This study confirms that ICG angiography is an important adjunctive method to fluorescein angiography. In more than 50% of eyes with O-CNV the ICG angiograms obtained with a scanning laser ophthalmoscope enable the visualization of a neovascular network in the early phase.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8911945

Source DB:  PubMed          Journal:  Ger J Ophthalmol        ISSN: 0941-2921


  2 in total

1.  Indocyanine green guided laser photocoagulation in patients with occult choroidal neovascularisation.

Authors:  A W Weinberger; H Knabben; U Solbach; S Wolf
Journal:  Br J Ophthalmol       Date:  1999-02       Impact factor: 4.638

2.  Evaluation of Idiopathic Choroidal Neovascularization with Indocyanine Green Angiography in Patients Undergoing Bevacizumab Therapy.

Authors:  Ryan B Rush; Sloan W Rush
Journal:  J Ophthalmol       Date:  2015-05-31       Impact factor: 1.909

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.